Zimmer Biomet reports increased net sales in first-quarter 2022 financial results
Click Here to Manage Email Alerts
Zimmer Biomet Holdings Inc. announced its first-quarter 2022 financial results, highlighted by increased net sales and the completion of the spinoff of ZimVie, according to a press release.
The company reported a first-quarter net sales of $1.663 billion, an increase of 3.9% from the prior year period. The company also reported net earnings of $73 million from continuing operations for the first quarter.
“We are encouraged by the better-than-expected results seen in Q1, driven by COVID recovery and continued execution by the Zimmer Biomet team. This performance increases our confidence level for 2022, and we are raising and tightening our guidance accordingly,” Bryan Hanson, chair, president and CEO of Zimmer Biomet, said in the release. “Our underlying business remains strong, fueled by innovation in our portfolio and an acceleration of our transformation activities. I continue to be proud of how the Zimmer Biomet team is executing against our mission so that we can serve health care providers and their patients while delivering value for shareholders,” Hanson added.
Read more about
Click Here to Manage Email Alerts